NYSE:TDOC (USA) Also trade in: Germany UK

Teladoc Health Inc

$ 68.55 0.02 (0.03%)
Volume: 593,514 Avg Vol (1m): 1,183,116
Market Cap $: 4.91 Bil Enterprise Value $: 4.88 Bil
P/E (TTM): 0.00 P/B: 4.84
Earnings Power Value -6.79
Net Current Asset Value -0.13
Tangible Book 0.41
Projected FCF 0
Median P/S Value 58.41
Graham Number 0
Peter Lynch Value 0
DCF (FCF Based) 0
DCF (Earnings Based) 0
1Y (-%)

Financial Strength : 6.2/10

GuruFocus Financial Strength Rank measures how strong a company's financial situation is . It is based on these factors
1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.
A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.
Current vs industry vs history
Cash-to-Debt 1.07
Cash-To-Debt range over the past 10 years
Min: 0.33, Med: 1.23, Max: 5.61
Current: 1.07
0.33
5.61
Equity-to-Asset 0.65
Equity-to-Asset range over the past 10 years
Min: 0.39, Med: 0.67, Max: 0.83
Current: 0.65
0.39
0.83
Debt-to-Equity 0.45
Debt-to-Equity range over the past 10 years
Min: 0.12, Med: 0.38, Max: 0.83
Current: 0.45
0.12
0.83
Debt-to-EBITDA -14.31
Debt-to-EBITDA range over the past 10 years
Min: -14.31, Med: -1.49, Max: -0.53
Current: -14.31
-14.31
-0.53
Piotroski F-Score 4
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 5.50
DISTRESS
GREY
SAFE
Beneish M-Score -2.21
Not Manipulator
Manipulator
WACC vs ROIC %
ROIC -7.89%
WACC 12.95%

Profitability & Growth : 5/10

GuruFocus Profitability Rank ranks how profitable a company is and how likely the company's business will stay that way.
Current vs industry vs history
Operating Margin % -15.39
Operating Margin range over the past 10 years
Min: -71.38, Med: -31.92, Max: -15.39
Current: -15.39
-71.38
-15.39
Net Margin % -22.63
Net Margin range over the past 10 years
Min: -74.98, Med: -42.46, Max: -22.63
Current: -22.63
-74.98
-22.63
ROE % -12.04
ROE range over the past 10 years
Min: -55.68, Med: -43.16, Max: -12.04
Current: -12.04
-55.68
-12.04
ROA % -7.79
ROA range over the past 10 years
Min: -36.08, Med: -24.91, Max: -7.79
Current: -7.79
-36.08
-7.79
ROC (Joel Greenblatt) % -471.37
ROC (Joel Greenblatt) range over the past 10 years
Min: -2142.41, Med: -1159.63, Max: -471.37
Current: -471.37
-2142.41
-471.37
3-Year Total Revenue Growth Rate 75.40
3-Year Revenue Growth Rate range over the past 10 years
Min: 17.8, Med: 38.7, Max: 59.2
Current: 17.8
17.8
59.2
3-Year Total EBITDA Growth Rate 15.50
3-Year EBITDA Growth Rate range over the past 10 years
Min: -82.3, Med: -19.3, Max: 43.3
Current: 43.3
-82.3
43.3
3-Year EPS w/o NRI Growth Rate 20.40
3-Year EPS w/o NRI Growth Rate range over the past 10 years
Min: 0, Med: -30.9, Max: 20.4
Current: 20.4
0
20.4

» TDOC's 30-Y Financials

Financials (Next Earnings Date: 2019-07-31)

Guru Trades Click for details

» Details

Insider Trades

SEC Filings

Gurus Latest Trades with NYSE:TDOC

» Interactive Chart

Peter Lynch Chart

Business Description

Industry Application Software » Application Software    NAICS : 621999    SIC : 8011
Compare XTER:COP SZSE:300253 NAS:PINC NAS:OMCL NAS:INOV NAS:MDSO HKSE:02666 NAS:HQY NYSE:EVH SZSE:300451 NAS:QSII NAS:TRHC NAS:HSTM NAS:RCM TSE:3902 LSE:CRW LSE:EMIS ASX:PME XPAR:CGM SHSE:603990
Traded in other countries 4LL.Germany 0LDR.UK
Address 2 Manhattanville Road, Suite 203, Purchase, NY, USA, 10577
Teladoc Inc is a telehealth platform that delivers 24-hour, on-demand healthcare via mobile devices, the Internet, video, and phone. Its platform connects members with a network of physicians and behavioral health professionals. The firm receives the majority of its revenue on a per-member-per-month basis from subscription access fees. The remainder of revenue comes from visit fees. Teledoc partners with employers, health plans, and health systems to offer its solutions to their members. Teledoc's platform matches members to healthcare providers in real time and is customizable for members, clients, and providers.

Ratios

Current vs industry vs history
PB Ratio 4.84
PB Ratio range over the past 10 years
Min: 2.29, Med: 4.11, Max: 7.13
Current: 4.84
2.29
7.13
PS Ratio 10.24
PS Ratio range over the past 10 years
Min: 4.19, Med: 8.74, Max: 14.64
Current: 10.24
4.19
14.64
Price-to-Operating-Cash-Flow 4570.00
Price-to-Operating-Cash-Flow range over the past 10 years
Min: 3440, Med: 3945, Max: 4773.32
Current: 4570
3440
4773.32
EV-to-EBIT -69.35
EV-to-EBIT range over the past 10 years
Min: -81.5, Med: -31.4, Max: -4.9
Current: -69.35
-81.5
-4.9
EV-to-EBITDA -155.34
EV-to-EBITDA range over the past 10 years
Min: -162.25, Med: -38.85, Max: -5.4
Current: -155.34
-162.25
-5.4
EV-to-Revenue 10.66
EV-to-Revenue range over the past 10 years
Min: 3.2, Med: 9, Max: 15.7
Current: 10.66
3.2
15.7
Current Ratio 7.54
Current Ratio range over the past 10 years
Min: 1.15, Med: 5.28, Max: 23.21
Current: 7.54
1.15
23.21
Quick Ratio 7.54
Quick Ratio range over the past 10 years
Min: 1.15, Med: 5.28, Max: 23.21
Current: 7.54
1.15
23.21
Days Sales Outstanding 40.41
Days Sales Outstanding range over the past 10 years
Min: 38.05, Med: 45.13, Max: 57.35
Current: 40.41
38.05
57.35
Days Payable 19.27
Days Payable range over the past 10 years
Min: 5.84, Med: 24.27, Max: 81.24
Current: 19.27
5.84
81.24

Dividend & Buy Back

Current vs industry vs history
3-Year Share Buyback Rate -19.60
3-Year Share Buyback Rate range over the past 10 years
Min: -19.8, Med: -19.6, Max: -18.7
Current: -19.6
-19.8
-18.7

Valuation & Return

Current vs industry vs history
Price-to-Tangible-Book 167.20
Price-to-Tangible-Book range over the past 10 years
Min: 3.95, Med: 10.28, Max: 224.87
Current: 167.2
3.95
224.87
Price-to-Median-PS-Value 1.17
Price-to-Median-PS-Value range over the past 10 years
Min: 0.47, Med: 0.96, Max: 1.68
Current: 1.17
0.47
1.68
Earnings Yield (Joel Greenblatt) % -1.45
Earnings Yield (Greenblatt) range over the past 10 years
Min: -20.4, Med: -3.2, Max: -1.2
Current: -1.45
-20.4
-1.2

More Statistics

Revenue (TTM) (Mil) $ 456.84
EPS (TTM) $ -1.52
Beta 1.88
Volatility % 58.4
52-Week Range $ 42.08 - 89.05
Shares Outstanding (Mil) 71.59

Analyst Estimate

Piotroski F-Score Details

Piotroski F-Score 4
Positive ROA N
Positive CFROA Y
Higher ROA yoy Y
CFROA > ROA Y
Lower Leverage yoy N
Higher Current Ratio yoy Y
Less Shares Outstanding yoy N
Higher Gross Margin yoy N
Higher Asset Turnover yoy N